                         SEQUENCE LISTING

<110>  Zander Therapeutics, Inc.
 
<120>  Small Molecule Agonists and Antagonists of NR2F6 Activity in 
       Non-Humans

<130>  83365-002WO(5)

<150>  16/008,526
<151>  2018-06-14

<150>  16/008,631
<151>  2018-06-14

<150>  15/820,324
<151>  2017-11-21

<150>  15/820,334
<151>  2017-11-21

<160>  1     

<170>  PatentIn version 3.5

<210>  1
<211>  1803
<212>  DNA
<213>  Homo Sapiens

<400>  1
gtgcagcccg tgccccccgc gcgccggggc cgaatgcgcg ccgcgtaggg tcccccgggc       60

cgagaggggt gcccggaggg aagagcgcgg tgggggcgcc ccggccccgc tgccctgggg      120

ctatggccat ggtgaccggc ggctggggcg gccccggcgg cgacacgaac ggcgtggaca      180

aggcgggcgg ctacccgcgc gcggccgagg acgactcggc ctcgcccccc ggtgccgcca      240

gcgacgccga gccgggcgac gaggagcggc cggggctgca ggtggactgc gtggtgtgcg      300

gggacaagtc gagcggcaag cattacggtg tcttcacctg cgagggctgc aagagctttt      360

tcaagcgaag catccgccgc aacctcagct acacctgccg gtccaaccgt gactgccaga      420

tcgaccagca ccaccggaac cagtgccagt actgccgtct caagaagtgc ttccgggtgg      480

gcatgaggaa ggaggcggtg cagcgcggcc gcatcccgca ctcgctgcct ggtgccgtgg      540

ccgcctcctc gggcagcccc ccgggctcgg cgctggcggc agtggcgagc ggcggagacc      600

tcttcccggg gcagccggtg tccgaactga tcgcgcagct gctgcgcgct gagccctacc      660

ctgcggcggc cggacgcttc ggcgcagggg gcggcgcggc gggcgcggtg ctgggcatcg      720

acaacgtgtg cgagctggcg gcgcggctgc tcttcagcac cgtggagtgg gcgcgccacg      780

cgcccttctt ccccgagctg ccggtggccg accaggtggc gctgctgcgc ctgagctgga      840

gcgagctctt cgtgctgaac gcggcgcagg cggcgctgcc cctgcacacg gcgccgctac      900

tggccgccgc cggcctccac gccgcgccta tggccgccga gcgcgccgtg gctttcatgg      960

accaggtgcg cgccttccag gaggaggtgg acaagctggg ccgcctgcag gtcgactcgg     1020

ccgagtatgg ctgcctcaag gccatcgcgc tttcacgccc gacgcctgtg gcctctcaga     1080

cccggcccac gttgagagcc tgcaggagaa ggcgcaggtg gccctcaccg agtatgtgcg     1140

ggcgcagtac ccgtcccagc cccagcgctt cgggcgcctg ctgctgcggc tccccgccct     1200

gcgcgcggtc cctgcctccc tcatctccca gctgttcttc atgcgcctgg tggggaagac     1260

gcccattgag acactgatca gagacatgct gctgtcgggg agtaccttca actggcccta     1320

cggctcgggc cagtgaccat gacggggcca cgtgtgctgt ggccaggcct gcagacagac     1380

ctcaagggac agggaatgct gaggcctcga ggggcctccc ggggcccagg actctggctt     1440

ctctcctcag acttctattt tttaaagact gtgaaatgtt tgtcttttct gttttttaaa     1500

tgatcatgaa accaaaaaga gactgatcat ccaggcctca gcctcatcct ccccaggacc     1560

cctgtccagg atggagggtc caatcctagg acagccttgt tcctcagcac ccctagcatg     1620

aacttgtggg atggtggggt tggcttccct ggcatgatgg acaaaggcct ggcgtcggcc     1680

agaggggctg ctccagtggg caggggtagc tagcgtgtgc caggcagatc ctctggacac     1740

gtaacctatg tcagacacta catgatgact caaggccaat aataaagaca tttcctacct     1800

gca                                                                   1803


